Powered by

At trial, portraits conflict:Pharmacy owner accused in fatalities

Barry Cadden broke down in tears when he learned of the first patient death from a tainted steroid prepared at Cadden's now defunct Framingham pharmacy, New England Compounding Center, a former top employee testified Monday.

That patient was among more than 60 people from nine states who died after receiving fungus-contaminated drugs prepared by Cadden's company, federal prosectors allege. Nearly 700 others were sickened in the 2012 nationwide outbreak of fungal meningitis that followed.

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox